Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma

Contributed equally
BMC Cancer201717:588

https://doi.org/10.1186/s12885-017-3595-8

Received: 6 February 2017

Accepted: 23 August 2017

Published: 29 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 Feb 2017 Submitted Original manuscript
7 Mar 2017 Reviewed Reviewer Report - Hideo Baba
15 Mar 2017 Reviewed Reviewer Report - Manuel Perucho
3 May 2017 Author responded Author comments - Seorin Jeong
Resubmission - Version 2
3 May 2017 Submitted Manuscript version 2
24 May 2017 Reviewed Reviewer Report - Hideo Baba
20 Jul 2017 Author responded Author comments - Seorin Jeong
Resubmission - Version 3
20 Jul 2017 Submitted Manuscript version 3
22 Jul 2017 Author responded Author comments - Seorin Jeong
Resubmission - Version 4
22 Jul 2017 Submitted Manuscript version 4
7 Aug 2017 Author responded Author comments - Seorin Jeong
Resubmission - Version 5
7 Aug 2017 Submitted Manuscript version 5
Publishing
23 Aug 2017 Editorially accepted
29 Aug 2017 Article published 10.1186/s12885-017-3595-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine
(2)
Department of Pathology, Seoul National University College of Medicine
(3)
Laboratory of Epigenetics, Cancer Research Institute, Department of Pathology, Seoul National University College of Medicine

Advertisement